Lataa...
Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice
Dengue virus (DENV) infection is a major global public health concern, and there is no effective vaccine for it. In this study, we describe the design and characterization of three nucleotide-modified mRNA vaccines (prME-mRNA, E80-mRNA, and NS1-mRNA) for DENV-2. Our results showed that vaccination w...
Tallennettuna:
Julkaisussa: | Mol Ther Methods Clin Dev |
---|---|
Päätekijät: | , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
American Society of Gene & Cell Therapy
2020
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7452130/ https://ncbi.nlm.nih.gov/pubmed/32913878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.07.013 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|